• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常温心脏停搏液可防止心脏停搏和再灌注期间细胞内钙的积聚。

Normothermic cardioplegia prevents intracellular calcium accumulation during cardioplegic arrest and reperfusion.

作者信息

Liu X, Engelman R M, Rousou J A, Flack J E, Deaton D W, Das D K

机构信息

Cardiovascular Division, University of Connecticut School of Medicine, Farmington.

出版信息

Circulation. 1994 Nov;90(5 Pt 2):II316-20.

PMID:7955273
Abstract

BACKGROUND

Development of intracellular calcium overloading is to be a primary factor in cellular injury during myocardial reperfusion. We studied the effects of different temperatures during continuously perfused cardioplegic arrest on the changes of intracellular calcium concentration ([Ca2+]i) level in isolated rat hearts.

METHODS AND RESULTS

Rat hearts were perfused by the Langendorff technique with Krebs-Henseleit bicarbonate (KHB) buffer. The [Ca2+]i was monitored by loading the heart with fura-2 acetoxymethyl ester and by using a [Ca2+]i analyzer. [Ca2+]i was calculated by determining the maximal and minimal fluorescent intensity for each heart. The hearts (n = 6 in each group) were subjected to cardioplegic arrest by continuous perfusion of oxygenated crystalloid K+ (15 mEq/L) cardioplegic solution (CPS) at different temperatures (4 degrees C, 20 degrees C, 28 degrees C, 37 degrees C) for 120 minutes, followed by 30 minutes of normothermic KHB buffer reperfusion. A fifth group received continuous perfusion as a control with 37 degrees C KHB buffer. The baseline values of [Ca2+]i were comparable in all experimental groups. In hearts perfused with 4 degrees C CPS, [Ca2+]i increased significantly during reperfusion (from 221 +/- 24 nmol/L [mean +/- SEM] at baseline to 341 +/- 19 at the end of reperfusion, P < .05). CPS perfusion at 20 degrees C also induced significant Ca2+ overloading during reperfusion, but not as much as in the 4 degrees C group. No significant [Ca2+]i increase occurred at 28 degrees C or 37 degrees C.

CONCLUSIONS

Continuous cardioplegic perfusion at lower temperatures (ie, 4 degrees C or 20 degrees C) induces Ca2+ overloading during reperfusion, which is detrimental to the optimal recovery of ventricular performance, while normothermic cardioplegic perfusion prevents the development of Ca2+ accumulation. These results provide experimental evidence for a detrimental effect of prolonged hypothermic continuous cardioplegia.

摘要

背景

细胞内钙超载的发生是心肌再灌注期间细胞损伤的主要因素。我们研究了持续灌注心脏停搏期间不同温度对离体大鼠心脏细胞内钙浓度([Ca2+]i)水平变化的影响。

方法与结果

采用Langendorff技术用Krebs-Henseleit碳酸氢盐(KHB)缓冲液灌注大鼠心脏。通过用fura-2乙酰氧基甲酯加载心脏并使用[Ca2+]i分析仪监测[Ca2+]i。通过确定每个心脏的最大和最小荧光强度来计算[Ca2+]i。心脏(每组n = 6)在不同温度(4℃、20℃、28℃、37℃)下通过持续灌注含氧晶体K+(15 mEq/L)心脏停搏液(CPS)120分钟进行心脏停搏,随后进行30分钟的常温KHB缓冲液再灌注。第五组接受37℃KHB缓冲液持续灌注作为对照。所有实验组的[Ca2+]i基线值相当。在用4℃CPS灌注的心脏中,再灌注期间[Ca2+]i显著增加(从基线时的221±24 nmol/L[平均值±标准误]增加到再灌注结束时的341±19,P <.05)。20℃下的CPS灌注在再灌注期间也诱导了显著的钙超载,但不如4℃组严重。在28℃或37℃时未发生显著的[Ca2+]i增加。

结论

较低温度(即4℃或20℃)下的持续心脏停搏灌注在再灌注期间诱导钙超载,这对心室功能的最佳恢复有害,而常温心脏停搏灌注可防止钙积累的发生。这些结果为长时间低温持续心脏停搏的有害作用提供了实验证据。

相似文献

1
Normothermic cardioplegia prevents intracellular calcium accumulation during cardioplegic arrest and reperfusion.常温心脏停搏液可防止心脏停搏和再灌注期间细胞内钙的积聚。
Circulation. 1994 Nov;90(5 Pt 2):II316-20.
2
Rapid cooling contracture of the myocardium. The adverse effect of prearrest cardiac hypothermia.心肌快速冷却挛缩。心脏骤停前低温的不良影响。
J Thorac Cardiovasc Surg. 1990 Aug;100(2):240-9.
3
The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.氧合心脏停搏液的温度和血细胞比容水平对心肌保护的影响。
J Thorac Cardiovasc Surg. 1988 Apr;95(4):625-30.
4
Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.蛋白激酶C亚型依赖性的缺血预处理和钾停搏心肌保护作用
J Thorac Cardiovasc Surg. 2001 Jan;121(1):137-48. doi: 10.1067/mtc.2001.111210.
5
Protection of the acutely injured heart--deleterious effects of hypothermia.
J Surg Res. 1994 Jan;56(1):108-11. doi: 10.1006/jsre.1994.1018.
6
Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.心肌保护:超短效β受体阻滞剂艾司洛尔作为心脏停搏液的疗效。
J Thorac Cardiovasc Surg. 2001 Nov;122(5):993-1003. doi: 10.1067/mtc.2001.115919.
7
Critical timing of nitric oxide supplementation in cardioplegic arrest and reperfusion.心脏停搏和再灌注期间一氧化氮补充的关键时机
Circulation. 1996 Nov 1;94(9 Suppl):II407-11.
8
Effects of supplemental L-arginine during warm blood cardioplegia.温血心脏停搏期间补充L-精氨酸的作用
Ann Thorac Cardiovasc Surg. 2000 Feb;6(1):27-33.
9
Influence of preconditioning on rat heart subjected to prolonged cardioplegic arrest.预处理对经历长时间心脏停搏的大鼠心脏的影响。
Ann Thorac Surg. 1996 Aug;62(2):469-74.
10
Warm nondepolarizing adenosine and lidocaine cardioplegia: continuous versus intermittent delivery.温性非去极化腺苷和利多卡因心脏停搏液:持续输注与间断输注
J Thorac Cardiovasc Surg. 2007 May;133(5):1171-8. doi: 10.1016/j.jtcvs.2006.12.058.

引用本文的文献

1
Warm Blood Cardioplegia for Myocardial Protection: Concepts and Controversies.温血停搏液在心肌保护中的应用:概念与争议。
Tex Heart Inst J. 2020 Apr 1;47(2):108-116. doi: 10.14503/THIJ-18-6909.
2
Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?高钾心脏停搏液在成人和儿科手术中的应用:一个时代的终结?
Front Physiol. 2013 Aug 28;4:228. doi: 10.3389/fphys.2013.00228. eCollection 2013.
3
Effects of sustained low-flow ischemia and reperfusion on Ca2+ transients and contractility in perfused rat hearts.持续低流量缺血及再灌注对灌注大鼠心脏Ca2+瞬变及收缩性的影响。
Mol Cell Biochem. 2001 Jan;216(1-2):111-9. doi: 10.1023/a:1011067529272.